Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Green Med Solution (BGMS) EBT (2016 - 2025)

Historic EBT for Bio Green Med Solution (BGMS) over the last 17 years, with Q3 2025 value amounting to -$988000.0.

  • Bio Green Med Solution's EBT rose 5440.7% to -$988000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.3 million, marking a year-over-year increase of 7296.73%. This contributed to the annual value of -$12.0 million for FY2024, which is 5291.77% up from last year.
  • Per Bio Green Med Solution's latest filing, its EBT stood at -$988000.0 for Q3 2025, which was up 5440.7% from -$1.3 million recorded in Q2 2025.
  • Bio Green Med Solution's EBT's 5-year high stood at -$81000.0 during Q1 2025, with a 5-year trough of -$9.0 million in Q4 2022.
  • Over the past 5 years, Bio Green Med Solution's median EBT value was -$5.6 million (recorded in 2022), while the average stood at -$4.6 million.
  • In the last 5 years, Bio Green Med Solution's EBT tumbled by 17582.78% in 2021 and then soared by 9811.63% in 2025.
  • Quarter analysis of 5 years shows Bio Green Med Solution's EBT stood at -$6.2 million in 2021, then tumbled by 44.32% to -$9.0 million in 2022, then surged by 36.74% to -$5.7 million in 2023, then surged by 66.73% to -$1.9 million in 2024, then skyrocketed by 47.84% to -$988000.0 in 2025.
  • Its EBT stands at -$988000.0 for Q3 2025, versus -$1.3 million for Q2 2025 and -$81000.0 for Q1 2025.